Remergin 2Million IU Injection
By Remergin
Rx
1 Injection in a Vial

Composition
Colistimethate Sodium(2Million IU)

Manufacturer - AstraZeneca
Corporate & Registered Office, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, 560045, Bangalore

Expires on or after
August, 2025

liver
Caution should be exercised when using Coligetz 2MIU Injection in patients with liver disease. Limited information is available on its use in these individuals. It is important to consult with your doctor before using this medication to ensure it is safe for you.

kidney
Coligetz 2MIU Injection requires caution in patients with kidney disease. Dose adjustment may be necessary. Consult your doctor.

alcohol
It is safe to consume alcohol while taking Remergin 2Million IU Injection with no harmful side effects.

driving
When taking Remergin 2Million IU Injection, be cautious while driving as it may reduce alertness and cause drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
Remergin 2Million IU Injection may not be safe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess risks and benefits before prescribing. Consult your doctor before using.

breastfeeding
Remergin 2Million IU Injection is likely safe for breastfeeding. Limited human data shows it carries no significant risk to the baby.
Habit Forming | No |
Chemical Class | Polypeptides |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Cell membrane active agent |
₹2298.6
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025